USANA Health Sciences Inc

Financials

Cash from operating activities 121.23 M103.9 M70.64 M60.99 M 31.52 M Cash from investing activities 14.19 M12.37 M11.97 M213.09 M 216.37 M Cash from financing activities 181.41 M30.09 M14.24 M9.55 M 50.23 M Free cash flow 108.46 M93.5 M56.15 M50.92 M 18.69 M

Usana Health Sciences, Inc., or USANA, is an American multi-level marketing company based in Salt Lake City, Utah. As of 2021, Usana was the 14th largest direct-selling company in the world by revenue. The company manufactures most of its nutritional products, dietary supplements, and skincare products at a Salt Lake City facility. Its products are sold in 24 countries via a network of independent distributors.

USNA

Financials

USANA Health Sciences Inc

News

Pacira BioSciences Q4 Earnings and Revenues Miss Estimates, Stock Down

Xenon Q4 Loss Wider Than Expected, Pipeline Development in Focus

Catalyst Pharmaceuticals Q4 Earnings Beat, Firdapse Revenues Rise Y/Y

ACAD Q4 Earnings Beat, Nuplazid & Daybue Drive Y/Y Revenue Growth

Usana Health Sciences: Chief legal officer Foukas sells $95k in shares

USNA or UTHR: Which Is the Better Value Stock Right Now?

Is Amneal Pharmaceuticals (AMRX) Stock Undervalued Right Now?

USANA Health Sciences, Inc. (USNA) Q4 2025 Earnings Call Transcript

USANA Health Sciences (USNA) Q4 Earnings and Revenues Beat Estimates

USANA Health Sciences earnings beat by $0.20, revenue topped estimates

Ionis Pharmaceuticals (IONS) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

Analysts Estimate USANA Health Sciences (USNA) to Report a Decline in Earnings: What to Look Out for